Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Cavaletti

Showing results (21-30 of 283) with videos related to

Pageof 29
Sort By:
Haematologica|November 21, 2007
Bortezomib-induced peripheral neurotoxicity: still far from a painless gainGuido Cavaletti, Eduardo Nobile-Orazio
Toxics|October 21, 2017
Toxicities of Therapeutic Agents Used in MedicineValentina Alda Carozzi, Guido Cavaletti
CNS & Neurological Disorders Drug Targets|November 11, 2008
Focus on the role of Glutamate in the pathology of the peripheral nervous systemValentina Carozzi, Paola Marmiroli, Guido Cavaletti
Current Medicinal Chemistry|April 10, 2009
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous systemAnnalisa Canta, Alessia Chiorazzi, Guido Cavaletti
The Lancet. Oncology|July 2, 2011
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomicsGuido Cavaletti, Paola Alberti, Paola Marmiroli
International Journal of Molecular Sciences|January 11, 2022
Rigosertib and Cholangiocarcinoma: A Cell Cycle AffairAlessio Malacrida, Guido Cavaletti, Mariarosaria Miloso
Micron (Oxford, England : 1993)|December 11, 2025
Morphometric analysis of axonal ultrastructure: Coordinated scaling of organelles and myelinVitalijs Borisovs, Mario Bossi, Guido Cavaletti
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?Guido Cavaletti, Paola Alberti, Paola Marmiroli
Experimental Neurology|November 21, 2021
Clinical and preclinical features of eribulin-related peripheral neuropathyOlga Tarasiuk, Guido Cavaletti, Cristina Meregalli
Cancers|November 11, 2022
HDACi: The Columbus' Egg in Improving Cancer Treatment and Reducing Neurotoxicity?Angelica Squarzoni, Arianna Scuteri, Guido Cavaletti
Pageof 29

Showing results (21-30 of 283) with videos related to

Sort By:
Pageof 29
Haematologica|November 21, 2007
Bortezomib-induced peripheral neurotoxicity: still far from a painless gainGuido Cavaletti, Eduardo Nobile-Orazio
Toxics|October 21, 2017
Toxicities of Therapeutic Agents Used in MedicineValentina Alda Carozzi, Guido Cavaletti
CNS & Neurological Disorders Drug Targets|November 11, 2008
Focus on the role of Glutamate in the pathology of the peripheral nervous systemValentina Carozzi, Paola Marmiroli, Guido Cavaletti
Current Medicinal Chemistry|April 10, 2009
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous systemAnnalisa Canta, Alessia Chiorazzi, Guido Cavaletti
The Lancet. Oncology|July 2, 2011
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomicsGuido Cavaletti, Paola Alberti, Paola Marmiroli
International Journal of Molecular Sciences|January 11, 2022
Rigosertib and Cholangiocarcinoma: A Cell Cycle AffairAlessio Malacrida, Guido Cavaletti, Mariarosaria Miloso
Micron (Oxford, England : 1993)|December 11, 2025
Morphometric analysis of axonal ultrastructure: Coordinated scaling of organelles and myelinVitalijs Borisovs, Mario Bossi, Guido Cavaletti
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?Guido Cavaletti, Paola Alberti, Paola Marmiroli
Experimental Neurology|November 21, 2021
Clinical and preclinical features of eribulin-related peripheral neuropathyOlga Tarasiuk, Guido Cavaletti, Cristina Meregalli
Cancers|November 11, 2022
HDACi: The Columbus' Egg in Improving Cancer Treatment and Reducing Neurotoxicity?Angelica Squarzoni, Arianna Scuteri, Guido Cavaletti
Pageof 29